Bococizumab is a remarkable anti-PCSK9 antibody specifically developed to treat hypercholesterolemia. It therapeutic agent interacts with the PCSK9 protein, a critical regulator of cholesterol amounts. By blocking the https://roxannggco060748.blogdigy.com/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia-64838406